HeyJaredBeta Finch - Eli Lilly - LLY - EN
AI-powered earnings call analysis for Eli Lilly (LLY). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.
- Indexed episodes, last 90 days
- 1
- Latest publication
- Aug 29, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 29, 2026
Latest episodes
Eli Lilly Q2 2026 Earnings Analysis (opens the original)
Read excerpt
More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're digging into Eli Lilly's Q2 2026 results, and Jordan, I'll just say it up front — this was a big one. JORDAN: Big is an understatement. But before we get into the numbers, our standard reminder: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be co
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.